Works by Kim, Jae‐Joon


Results: 65
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 19, p. 2966, doi. 10.1002/cncr.34892
    By:
    • Lee, Jiyun;
    • Park, Sehhoon;
    • Jung, Hyun Ae;
    • Lee, Se‐Hoon;
    • Seo, Seyoung;
    • Kim, Sung‐Bae;
    • Kim, Ji‐Won;
    • Lee, Keun‐Wook;
    • Kang, Eun Joo;
    • Kim, Ju Won;
    • Choi, Yoon Ji;
    • Shim, Byoung‐Yong;
    • An, Ho‐Jung;
    • Park, Lee Chun;
    • Shin, Seong Hoon;
    • Kim, Jae‐Joon;
    • Oh, So Yeon;
    • Kim, Min Kyoung;
    • Ahn, Myung‐Ju
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06).

    Published in:
    BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11972-w
    By:
    • Lim, Sung Hee;
    • Lee, Keun-Wook;
    • Kim, Jae-Joon;
    • Im, Hyeon-Su;
    • Kim, In-Ho;
    • Han, Hye Sook;
    • Koo, Dong-Hoe;
    • Cho, Jang Ho;
    • Maeng, Chi Hoon;
    • Lee, Min-Young;
    • Lee, Hyo Jin;
    • Kim, Jwa Hoon;
    • Park, Sang Gon;
    • Jung, Joo Young;
    • Shin, Seong-Hoon;
    • Kim, Ki Hyang;
    • Kim, Hyeyeong;
    • Oh, So Yeon;
    • Kang, Minsu;
    • Jung, Minkyu
    Publication type:
    Article
    46
    47
    48
    49
    50